<page><title>Koolen-de Vries syndrome</title><url>https://medlineplus.gov/genetics/condition/koolen-de-vries-syndrome</url><content>Koolen-de Vries syndrome
To use the sharing features on this page, please enable JavaScript.
Description
Koolen-de Vries syndrome is a disorder characterized by developmental delay and mild to moderate intellectual disability. People with this disorder typically have a disposition that is described as cheerful, sociable, and cooperative. They usually have weak muscle tone (hypotonia) in childhood. About half have recurrent seizures (epilepsy).
Affected individuals often have distinctive facial features including a high, broad forehead; droopy eyelids (ptosis); a narrowing of the eye openings (blepharophimosis); outer corners of the eyes that point upward (upward-slanting  palpebral  fissures); skin folds covering the inner corner of the eyes (epicanthal folds); a bulbous nose; and prominent ears. Males with Koolen-de Vries syndrome often have undescended testes (cryptorchidism). Defects in the walls between the chambers of the heart (septal defects) or other cardiac abnormalities, kidney problems, and skeletal anomalies such as foot deformities occur in some affected individuals.
Frequency
The prevalence of Koolen-de Vries syndrome is estimated to be 1 in 16,000. However, the underlying genetic cause is often not identified in people with intellectual disability, so this condition is likely underdiagnosed.
Causes
Koolen-de Vries syndrome is caused by genetic changes that eliminate the function of one copy of the
KANSL1
gene in each cell. Most affected individuals are missing a small amount of genetic material, including the
KANSL1
gene, from one copy of
chromosome 17
. This type of genetic abnormality is called a microdeletion. A small number of individuals with Koolen-de Vries syndrome do not have a chromosome 17 microdeletion but instead have a mutation within the
KANSL1
gene that causes one copy of the gene to be nonfunctional.
The microdeletion that causes Koolen-de Vries syndrome occurs on the long (q) arm of chromosome 17 at a location designated q21.31. While the exact size of the deletion varies among affected individuals, most are missing a sequence of about 500,000 DNA building blocks (base pairs) containing several genes. However, because individuals with
KANSL1
gene mutations have the same signs and symptoms as those with the microdeletion, researchers have concluded that the loss of this gene accounts for the features of this disorder.
The
KANSL1
gene provides instructions for making a protein that helps regulate gene activity (expression) by modifying
chromatin
. Chromatin is the complex of DNA and protein that packages DNA into chromosomes. The protein produced from the
KANSL1
gene is found in most organs and tissues of the body before birth and throughout life. By its involvement in controlling the activity of other genes, this protein plays an important role in the development and function of many parts of the body. Loss of one copy of this gene impairs normal development and function, but the  relationship of
KANSL1
gene loss to the specific signs and symptoms of Koolen-de Vries syndrome is unclear.
Learn more about the gene and chromosome associated with Koolen-de Vries syndrome
KANSL1
chromosome 17
Inheritance
Koolen-de Vries syndrome is considered an
autosomal dominant
condition because a deletion or mutation affecting one copy of the
KANSL1
gene in each cell is sufficient to cause the disorder. In most cases, the disorder is not inherited. The genetic change occurs most often as a random event during the formation of reproductive cells (eggs and sperm) or in early fetal development. Affected people typically have no history of the disorder in their family. While it is possible for them to pass the condition on to their children, no individuals with Koolen-de Vries syndrome have been known to reproduce.
Most people with Koolen-de Vries syndrome caused by a deletion have had at least one parent with a common variant of the 17q21.31 region of chromosome 17 called the H2 lineage. This variant is found in 20 percent of people of European and Middle Eastern descent, although it is rare in other populations. In the H2 lineage, a 900 kb segment of DNA, which includes the region deleted in most cases of Koolen-de Vries syndrome, has undergone an
inversion
. An inversion involves two breaks in a chromosome; the resulting piece of DNA is reversed and reinserted into the chromosome.
People with the H2 lineage have no health problems related to the inversion. However, genetic material can be lost or duplicated when the inversion is passed to the next generation. Other, unknown factors are thought to play a role in this process. So while the inversion is very common, only an extremely  small percentage of parents with the inversion have a child affected by Koolen-de Vries syndrome.
Other Names for This Condition
17q21.31 deletion syndrome
17q21.31 microdeletion syndrome
Chromosome 17q21.31 microdeletion syndrome
KANSL1-related intellectual disability syndrome
KDVS
Koolen syndrome
Microdeletion 17q21.31 syndrome
Monosomy 17q21.31
Additional Information &amp; Resources
Genetic Testing Information
Genetic Testing Registry: Koolen-de Vries syndrome
Genetic and Rare Diseases Information Center
Koolen-De Vries syndrome
Patient Support and Advocacy Resources
National Organization for Rare Disorders (NORD)
Clinical Trials
ClinicalTrials.gov
Catalog of Genes and Diseases from OMIM
KOOLEN-DE VRIES SYNDROME; KDVS
Scientific Articles on PubMed
PubMed
References
Dubourg C, Sanlaville D, Doco-Fenzy M, Le Caignec C, Missirian C, Jaillard S,
Schluth-Bolard C, Landais E, Boute O, Philip N, Toutain A, David A, Edery P,
Moncla A, Martin-Coignard D, Vincent-Delorme C, Mortemousque I, Duban-Bedu B,
Drunat S, Beri M, Mosser J, Odent S, David V, Andrieux J. Clinical and molecular
characterization of 17q21.31 microdeletion syndrome in 14 French patients with
mental retardation. Eur J Med Genet. 2011 Mar-Apr;54(2):144-51. doi:
10.1016/j.ejmg.2010.11.003. Epub 2010 Nov 20.
Citation on PubMed
Egger JI, Wingbermuhle E, Verhoeven WM, Dijkman M, Radke S, de Bruijn ER, de
Vries B, Kessels RP, Koolen D. Hypersociability in the behavioral phenotype of
17q21.31 microdeletion syndrome. Am J Med Genet A. 2013 Jan;161A(1):21-6. doi:
10.1002/ajmg.a.35652. Epub 2012 Nov 20.
Citation on PubMed
Itsara A, Vissers LE, Steinberg KM, Meyer KJ, Zody MC, Koolen DA, de Ligt J,
Cuppen E, Baker C, Lee C, Graves TA, Wilson RK, Jenkins RB, Veltman JA, Eichler
EE. Resolving the breakpoints of the 17q21.31 microdeletion syndrome with
next-generation sequencing. Am J Hum Genet. 2012 Apr 6;90(4):599-613. doi:
10.1016/j.ajhg.2012.02.013.
Citation on PubMed
or
Free article on PubMed Central
Koolen DA, Kramer JM, Neveling K, Nillesen WM, Moore-Barton HL, Elmslie FV,
Toutain A, Amiel J, Malan V, Tsai AC, Cheung SW, Gilissen C, Verwiel ET, Martens
S, Feuth T, Bongers EM, de Vries P, Scheffer H, Vissers LE, de Brouwer AP,
Brunner HG, Veltman JA, Schenck A, Yntema HG, de Vries BB. Mutations in the
chromatin modifier gene KANSL1 cause the 17q21.31 microdeletion syndrome. Nat
Genet. 2012 Apr 29;44(6):639-41. doi: 10.1038/ng.2262.
Citation on PubMed
Koolen DA, Morgan A, de Vries BBA. Koolen-de Vries Syndrome. 2010 Jan 26
[updated 2023 Feb 2]. In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE,
Bean LJH, Gripp KW, Amemiya A, editors. GeneReviews(R) [Internet].
Seattle (WA): University of Washington, Seattle; 1993-2024. Available from
http://www.ncbi.nlm.nih.gov/books/NBK24676/
Citation on PubMed
Koolen DA, Sharp AJ, Hurst JA, Firth HV, Knight SJ, Goldenberg A,
Saugier-Veber P, Pfundt R, Vissers LE, Destree A, Grisart B, Rooms L, Van der Aa
N, Field M, Hackett A, Bell K, Nowaczyk MJ, Mancini GM, Poddighe PJ, Schwartz CE,
Rossi E, De Gregori M, Antonacci-Fulton LL, McLellan MD 2nd, Garrett JM, Wiechert
MA, Miner TL, Crosby S, Ciccone R, Willatt L, Rauch A, Zenker M, Aradhya S,
Manning MA, Strom TM, Wagenstaller J, Krepischi-Santos AC, Vianna-Morgante AM,
Rosenberg C, Price SM, Stewart H, Shaw-Smith C, Brunner HG, Wilkie AO, Veltman
JA, Zuffardi O, Eichler EE, de Vries BB. Clinical and molecular delineation of
the 17q21.31 microdeletion syndrome. J Med Genet. 2008 Nov;45(11):710-20. doi:
10.1136/jmg.2008.058701. Epub 2008 Jul 15. Erratum In: J Med Genet. 2009
Aug;46(8):576.
Citation on PubMed
or
Free article on PubMed Central
Koolen DA, Vissers LE, Pfundt R, de Leeuw N, Knight SJ, Regan R, Kooy RF,
Reyniers E, Romano C, Fichera M, Schinzel A, Baumer A, Anderlid BM, Schoumans J,
Knoers NV, van Kessel AG, Sistermans EA, Veltman JA, Brunner HG, de Vries BB. A
new chromosome 17q21.31 microdeletion syndrome associated with a common inversion
polymorphism. Nat Genet. 2006 Sep;38(9):999-1001. doi: 10.1038/ng1853. Epub 2006
Aug 13.
Citation on PubMed
Sharkey FH, Morrison N, Murray R, Iremonger J, Stephen J, Maher E, Tolmie J,
Jackson AP. 17q21.31 microdeletion syndrome: further expanding the clinical
phenotype. Cytogenet Genome Res. 2009;127(1):61-6. doi: 10.1159/000279260. Epub
2010 Jan 27.
Citation on PubMed
Stefansson H, Helgason A, Thorleifsson G, Steinthorsdottir V, Masson G,
Barnard J, Baker A, Jonasdottir A, Ingason A, Gudnadottir VG, Desnica N, Hicks A,
Gylfason A, Gudbjartsson DF, Jonsdottir GM, Sainz J, Agnarsson K, Birgisdottir B,
Ghosh S, Olafsdottir A, Cazier JB, Kristjansson K, Frigge ML, Thorgeirsson TE,
Gulcher JR, Kong A, Stefansson K. A common inversion under selection in
Europeans. Nat Genet. 2005 Feb;37(2):129-37. doi: 10.1038/ng1508. Epub 2005 Jan
16.
Citation on PubMed
Tan TY, Aftimos S, Worgan L, Susman R, Wilson M, Ghedia S, Kirk EP, Love D,
Ronan A, Darmanian A, Slavotinek A, Hogue J, Moeschler JB, Ozmore J, Widmer R,
Bruno D, Savarirayan R, Peters G. Phenotypic expansion and further
characterisation of the 17q21.31 microdeletion syndrome. J Med Genet. 2009
Jul;46(7):480-9. doi: 10.1136/jmg.2008.065391. Epub 2009 May 15. Erratum In: J
Med Genet. 2009 Aug;46(8):576. Bruno, Damien [added].
Citation on PubMed
Zollino M, Orteschi D, Murdolo M, Lattante S, Battaglia D, Stefanini C,
Mercuri E, Chiurazzi P, Neri G, Marangi G. Mutations in KANSL1 cause the 17q21.31
microdeletion syndrome phenotype. Nat Genet. 2012 Apr 29;44(6):636-8. doi:
10.1038/ng.2257.
Citation on PubMed
The information on this site should not be used as a substitute for professional medical care or advice. Contact a health care provider if you have questions about your health.
Official websites use .gov
A
.gov
website belongs to an official government
              organization in the United States.
Secure .gov websites use HTTPS
A
lock
(
Lock
Locked padlock icon
) or
https://
means youâ€™ve safely connected to
              the .gov website. Share sensitive information only on official,
              secure websites.</content></page>